CMS Measure ID: #102 Collection Type: CQM Reporting Frequency: Once per episode of treatment Outcome: No High Priority: Yes NQS Domain: Efficiency and CostContinue reading “2023 # 102 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients”
CQM/eCQM Archive
2023 # 066 Appropriate Testing for Pharyngitis
CMS Measure ID: #66 Collection Type: CQM Reporting Frequency: Every visit Outcome: No High Priority: Yes NQS Domain: Efficiency and Cost Reduction Measure Age:Continue reading “2023 # 066 Appropriate Testing for Pharyngitis”
2023 # 065 Appropriate Treatment for Upper Respiratory Infection (URI)
CMS Measure ID: #65 Collection Type: CQM Reporting Frequency: Every visit Outcome: No High Priority: Yes NQS Domain: Efficiency and Cost Reduction Measure Age:Continue reading “2023 # 065 Appropriate Treatment for Upper Respiratory Infection (URI)”
2023 # 019 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS Measure ID: #19 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Communication and CareContinue reading “2023 # 019 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care”
2023 # 008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS Measure ID: #8 Collection Type: CQM Reporting Frequency: 1: Once per patient/year; 2: Every Visit Outcome: No High Priority: No NQS Domain: EffectiveContinue reading “2023 # 008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2023 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)
CMS Measure ID: #7 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)"
2023 # 005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS Measure ID: #5 Collection Type: CQM Reporting Frequency: 1: Once per patient/year; 2: Every Visit Outcome: No High Priority: No NQS Domain: EffectiveContinue reading “2023 # 005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”